A comparative study of sexual dysfunction in clinically stable schizophrenic patients receiving trifluoperazine, risperidone, and olanzapine

Background: Sexual dysfunction (SD) is a common occurrence in Schizophrenia on antipsychotics, both typical and atypical. Indian studies this regard are not many number. Aims Objectives: The aims of study were to investigate SD Schizophrenics Trifluoperazine, Risperidone, Olanzapine also evaluate the incidence relation duration illness, treatment, dosage drugs each group subjects. Materials Methods: In stable schizophrenic patients, Trifluoperazine (n=40), Risperidone was assessed using Arizona sexual experience scale. Demographic profile treatment drug evaluated group. Comparisons made between patients taking atypical antipsychotics. Furthermore, distribution with dose subjects (taking or Olanzapine). Results: (1) Majority males (66.67%) above 30 years (55%). (2) Incidence higher antipsychotics (statistically insignificant). (3) Increased associated SD. Patients treated for longer had (P<0.05). Conclusion: older age groups Antipsychotics. doses, all